Synlogic_Logo_Blue.png
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
29 sept. 2023 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic_Logo_Blue.png
Synlogic to Participate in Chardan’s Genetic Medicines Conference
21 sept. 2023 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Screenshot_2.jpg
AlphaTime Acquisition Corp Announces Pricing of $60 Million Initial Public Offering
30 déc. 2022 16h05 HE | AlphaTime Acquisition Corp.
Cayman Islands, Dec. 30, 2022 (GLOBE NEWSWIRE) -- AlphaTime Acquisition Corp (the “Company”) today announced the pricing of its initial public offering of 6,000,000 units at a price of $10.00 per...
Chardan Logo.png
Chardan NexTech Acquisition 2 Corp. Shareholders Approve Previously Announced Business Combination with Dragonfly Energy, Corp.
06 oct. 2022 16h05 HE | Dragonfly Energy Corp.
RENO, Nev., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Chardan NexTech Acquisition 2 Corp. (“CNTQ”) (Nasdaq: CNTQ), a publicly traded special purpose acquisition company, today announced that its...
Logo.png
IMUNON to Present at Chardan’s 6th Annual Genetic Medicines Conference
27 sept. 2022 08h30 HE | Imunon, Inc.
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, today announced that Dr. Corinne Le Goff, President and Chief...
Synlogic Logo (no background).png
Synlogic To Present at Upcoming Investor and Industry Conferences
24 févr. 2022 07h00 HE | Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
WinVest Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
17 sept. 2021 12h32 HE | WinVest Acquisition Corp.
Cambridge, MA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINVU, the “Company”) announced today that it closed its initial public offering of 10,000,000 units at a price...
precision_logo.jpg
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
28 sept. 2020 07h00 HE | Precision Biosciences
DURHAM, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
Beamz Interactive, Inc. Signs Agreement With New York-Based Chardan Capital Markets
15 avr. 2014 08h01 HE | Beamz Interactive, Inc.
SCOTTSDALE, AZ--(Marketwired - Apr 15, 2014) - Beamz Interactive, Inc. (OTCQB: BZIC), a leading developer of state-of-the-art interactive music products, signed an agreement with Chardan Capital...
Worlds Finalizes Settlement With Investor Group, Retains Chardan Capital
22 juil. 2013 07h30 HE | Worlds Inc.
BOSTON, MA--(Marketwired - Jul 22, 2013) - Worlds Inc. (OTCBB: WDDD) received a majority of shareholder votes at its annual shareholder meeting on July 18th in support of Worlds' recent request to...